BiotechnologyHealthcareResearch

Implantable Wafer Shows Promise in Preventing Brain Tumor Recurrence by Reprogramming Immune Cells

A novel implantable wafer technology could transform glioblastoma treatment by locally reprogramming tumor-associated immune cells. The approach demonstrates significant survival benefits in preclinical models without systemic toxicity.

Breakthrough Approach to Brain Cancer Treatment

Researchers have developed an innovative implantable wafer that slowly releases immune-stimulating compounds to prevent glioblastoma recurrence, according to a recent study published in Nature Biomedical Engineering. The technology targets immunosuppressive myeloid cells that typically hinder effective cancer treatment, sources indicate.